Companies: 10,795·Total market cap: $144.5T

Rallybio Corporation

Rallybio Corporation

RLYBNASDAQHealthcare● Active

$15.91

$-0.04(-0.25%)

Market Cap$84293407

P/E Ratio—

52W High$17.574

52W Low$2.4

Avg Volume268K

Open$16.13

Beta-0.88

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Rallybio Corporation（RLYB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · RLYB · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.49Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)858000.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding5.6MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 Rallybio Corporation 数据

分析师预测$— · Buy

股息不分红

营收$858000+34.91%

盈利EPS $-1.59+85.06%

财务快照

FY 2025Revenue$858000.00▲ +34.91% YoY

202320242025

FY 2025Net Income-$9.0M▲ +84.46% YoY

202320242025

FY 2025EPS$-1.59▲ +85.06% YoY

202320242025

TTM:Revenue: $858000.00Net Income: -$7.8MEPS: $-1.49View income statement →

分析师评级与目标价

Buy8 位分析师

Strong Buy

0

Buy

4

Hold

4

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$15.91Current

$—Avg Target

$—High

合计: 8 · 买入占比: 50.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Rallybio Corporation

$15.91-0.25%$84.3M #2

Boundless Bio, Inc.

$1.43+0.70%$32.1M #3

Cadrenal Therapeutics, Inc. Common Stock

$4.21-5.18%$12.1M #4

$1.73-4.95%$27.3M #5

Intensity Therapeutics, Inc.

$3.78+0.27%$7.1M #6

Iterum Therapeutics plc

$0.03-10.98%$1.6M

股票表现

1D-0.25%

1W-1.55%

1M+10.64%

3M+45.83%

YTD+189.80%

1Y+430.33%

5Y-85.90%

关于 Rallybio Corporation

CEOStephen Uden

IPO DateJul 29, 2021

Employees15

CountryUS

Websiterallybio.com

Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Its most adva…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Rallybio Corporation（RLYB）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 29, 2021 在 NASDAQ 上市。截至最近交易日，RLYB 股价为 $15.91，市值约为 $84.3M。过去12个月累计回报 +430.33%，年初至今回报 +189.80%。

根据 8 位华尔街分析师，Rallybio Corporation 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Rallybio Corporation 营收 $858000.00，净利润 -$9.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Rallybio Corporation（RLYB）股价为 $15.91，在 NASDAQ 上市，52周区间为 $2.40 – $17.57。

RLYB 最新股价RLYB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议